AlphAIalphai — Financial news for AI agents
finance.yahoo.comJUN 24 min read$MDBBullishMed

MongoDB (MDB) Soars 20.4% as UBS Raises PT by Double-Digits

MongoDB shares rose 20.36% to close at $403.88 on Monday, extending a three-day winning streak. UBS raised its price target 27% to $350 from $275 while keeping a neutral rating. UBS cited MongoDB’s Q1 FY2027 shift to profit of $4.4M and revenue up 25% to $687.6M; MongoDB guided Q2 revenue to $729M–$734M.

AI DeskJune 2, 2026
Source · finance.yahoo.com
AI analysis
Relevance
9/10
Novelty
6/10
Actionability
Med
Sentiment · $MDB
Bullish
Timing
after-hours/early session reaction to UBS PT upgrade and latest Q1/Q2 guidance
Market alignment
positive (analyst PT raise) but tempered (neutral stance)
Why this matters for $MDB

UBS’s PT raise plus upbeat Q1 results and Q2 revenue guidance likely supports near-term momentum, though UBS stayed neutral.

Relevance context

MongoDB shares surged after UBS raised its price target by 27% following the company’s Q1 FY27 profit and revenue growth.

Price-impact prediction

Bullish bias for follow-through, but upside may be capped by the neutral rating and the PT still below the recent close.

Background

MongoDB reported Q1 FY27 results (profit turnaround and revenue growth) and is now seeing analyst PT support after the print.

Why it matters

The combination of a profit swing, 25% YoY revenue growth, and raised Q2 revenue outlook can extend momentum, but the neutral rating implies investors may need additional upside evidence for further rerating.

Market relevance

This is a single-name catalyst: an analyst PT raise layered on top of reported earnings and forward revenue guidance, aligning with the observed sharp price move.

Market effects

Sector

Reinforces positive sentiment toward database/data-platform software names tied to subscription growth and AI-adjacent enterprise demand.

Regional

Primarily US tech/enterprise software sentiment; no specific regional linkage cited.

Global

Limited—no global macro or cross-border deal/regulatory catalyst mentioned.

Alternative perspectives

Contrarian view

The stock’s move may already price in the UBS upgrade; UBS’s neutral stance and PT below the latest close suggest risk of mean reversion.

Overlooked factors

Follow-through depends on whether Q2 revenue guidance (implied 23–24% growth) is enough to shift UBS from neutral to positive, and whether subscription/service mix sustains.

Key entities

  • company
    MongoDB Inc.

    Subject of the article; shares jumped ~20% and UBS raised its PT after Q1 FY27 results and Q2 guidance.

  • analyst_firm
    UBS

    Raised MongoDB’s price target to $350 from $275 while keeping a neutral stance.

Read at source← All news

Related articles

JUN 5
$MDBMedAI 9/10

MongoDB Is the Latest SaaS Apocalypse Victim to Say Not Today

MongoDB shares rose nearly 40% from pre-earnings levels after the company’s blowout earnings report last week, which the article says beat expectations across key metrics and reduced concerns that AI would hurt growth. It also notes analysts raised price targets afterward, with some projecting about 20% additional upside from current levels.

finance.yahoo.com6 min
JUN 4
$SNOWLow

Snowflake vs. MongoDB: Which Technology Stock Is a Better Buy in 2026?

The article compares Snowflake (SNOW) and MongoDB (MDB) as cloud data infrastructure plays. Snowflake reported FY2026 revenue near $4.7B (+29.2%) and a net loss about $1.3B; it also cited a debt-to-equity ratio ~1.4x and free cash flow ~ $1.1B. MongoDB reported FY2026 revenue about $2.5B (+22.8%) and a net loss ~ $71.2M; it cited near-zero debt-to-equity, current ratio ~4.7x, and free cash flow ~ $500.2M.

fool.com7 min
JUN 3
$SNOWLow

Snowflake vs. MongoDB: Which Technology Stock Is a Better Buy in 2026?

The article compares Snowflake and MongoDB for 2026. Snowflake’s balance sheet (Jan 2026) shows ~0.0x debt-to-equity and a ~4.7x current ratio; free cash flow was about $500.2M, but stock-based compensation was ~109% of operating cash flow. It cites 2024 account-access issues and reliance on Amazon infrastructure. MongoDB is described as trading at lower valuation multiples, with Atlas dependence and legal uncertainty around its server-side public license.

finance.yahoo.com6 min
JUN 1
$MDBMedAI 9/10

MongoDB (MDB) Stock Trades Up, Here Is Why

MongoDB shares rose 17.9% in the afternoon after its May 28 earnings beat and a broader software-sector rotation, according to the article. For Q1 FY2027, revenue was $687.6M (+25% YoY) vs. $664.5M expected; adjusted EPS was $1.32 vs. $1.19. Atlas revenue grew 29.4% to $512.5M; free cash flow was $197.5M. Guidance was raised to $2.92–$2.96B revenue and $5.95–$6.14 EPS.

markets.financialcontent.com4 min
MAY 31
$SNOWMedAI 9/10

Software Was the Market's Big Laggard This Year. Snowflake's Blowout Might Be the Spark That Changes That.

Software stocks lagged early 2026 despite gains in the S&P 500, and Snowflake shares fell more than 50% from a year earlier in April. After fiscal Q1 ended April 30, Snowflake reported product revenue up 34% to $1.33B, non-GAAP operating margin rising to 12%, and EPS of $0.39. Management lifted full-year product revenue guidance to $5.84B and said AI is increasing data/workload consumption; Datadog and MongoDB also reported accelerating results.

fool.com6 min